AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Balancing Public Benefit and Private Profit in Nonprofit Drug Development
The comparison between the timelines of phase two trials for maps and compasses indicates the advantages of private funding in terms of pace and scale. The model of nonprofit drug development, exemplified by Rig Dublin's directed maps, disrupts the balance between public benefit and private profit. As these therapies move towards commercialization, they face challenges in securing funding. There is a shift in focus from drug approvals to accessibility, raising questions about cost, coverage, indications, and off-label prescribing.